Stay updated on XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial

Sign up to get notified when there's something new on the XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-28T16:35:27.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A banner was added announcing NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” and linking to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-21T21:36:52.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The site footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-14T21:40:38.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-07T21:56:20.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The page displays a 403 Forbidden error for the study record, indicating that access to the content is blocked or unavailable. This reflects an access restriction rather than a substantive update to the study details.
    Difference
    0.2%
    Check dated 2026-09-30T22:08:17.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content, indicating the study page is currently inaccessible. This prevents viewing the study details and related navigation until access is restored.
    Difference
    19%
    Check dated 2026-09-23T21:36:48.000Z thumbnail image

Stay in the know with updates to XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial

Enter your email address, and we'll notify you when there's something new on the XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial page.